{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:43:57Z","timestamp":1766407437275,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.puhe.2023.10.021","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T08:29:36Z","timestamp":1699604976000},"page":"263-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Informing the use of a supplementary immunisation programme for the management of a community cluster of invasive meningococcal disease, Yorkshire, 2022"],"prefix":"10.1016","volume":"225","author":[{"given":"A.J.","family":"Irvine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wensley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-0117","authenticated-orcid":false,"given":"G.J.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-3623","authenticated-orcid":false,"given":"S.A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Leaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9721-7355","authenticated-orcid":false,"given":"M.E.","family":"Vergis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Guidance for public health management of meningococcal disease in the UK","key":"10.1016\/j.puhe.2023.10.021_bib1"},{"issue":"12","key":"10.1016\/j.puhe.2023.10.021_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.puhe.2023.10.021_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.micinf.2011.02.006","article-title":"Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains","volume":"13","author":"Bertrand","year":"2011","journal-title":"Microb Infect"},{"issue":"1","key":"10.1016\/j.puhe.2023.10.021_bib4","first-page":"e58","article-title":"The epidemiology and management of clusters of invasive meningococcal disease in England, 2010-15","volume":"42","author":"Gobin","year":"2020","journal-title":"J\u00a0Public Health"},{"issue":"4","key":"10.1016\/j.puhe.2023.10.021_bib5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s40121-021-00499-3","article-title":"Meningococcal disease outbreaks: a moving target and a case for routine preventative vaccination","volume":"10","author":"Soumahoro","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"Pt 7","key":"10.1016\/j.puhe.2023.10.021_bib6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and wales 1993\/94 to 2003\/04: contribution and experiences of the meningococcal reference unit","volume":"55","author":"Gray","year":"2006","journal-title":"J\u00a0Med Microbiol"},{"issue":"5","key":"10.1016\/j.puhe.2023.10.021_bib7","first-page":"385","article-title":"Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England","volume":"87","author":"Clark","year":"2023","journal-title":"J\u00a0Infect"},{"issue":"28","key":"10.1016\/j.puhe.2023.10.021_bib8","doi-asserted-by":"crossref","first-page":"1700590","DOI":"10.2807\/1560-7917.ES.2018.23.28.1700590","article-title":"Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination","volume":"23","author":"Thabuis","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.puhe.2023.10.021_bib9","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1186\/s12889-020-09487-7","article-title":"Targeted vaccination campaigns of teenagers after two clusters of B invasive meningococcal disease in Brittany, France, 2017","volume":"20","author":"Pivette","year":"2020","journal-title":"BMC Publ Health"},{"issue":"9","key":"10.1016\/j.puhe.2023.10.021_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/cix154","article-title":"Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada","volume":"64","author":"De Wals","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062300389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003335062300389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:44:10Z","timestamp":1758501850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003335062300389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":10,"alternative-id":["S003335062300389X"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2023.10.021","relation":{},"ISSN":["0033-3506"],"issn-type":[{"type":"print","value":"0033-3506"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Informing the use of a supplementary immunisation programme for the management of a community cluster of invasive meningococcal disease, Yorkshire, 2022","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2023.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}]}}